Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Intelgenx Technologs (TSV: IGX )

0.2050 CAD UNCHANGED
Streaming Delayed Price Updated: 2:20 PM EDT, Sep 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2050
Bid (Size) 0.2000 (65)
Ask (Size) 0.2350 (45)
Prev. Close 0.2050
Today's Range 0.2050 - 0.2050
52wk Range 0.1600 - 0.9400
Shares Outstanding 70,026,128
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
IntelGenx and Exeltis Healthcare S.L. Expand RIZAPORT® Commercialization Agreement to Include the European Union
From GlobeNewswire News Releases
IntelGenx Amends Stock Options
From GlobeNewswire News Releases

Performance

YTD
-67.46%
-67.46%
1 Month
-2.38%
-2.38%
3 Month
-28.07%
-28.07%
6 Month
-50.00%
-50.00%
1 Year
-72.30%
-72.30%

More News

Read More
ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines
From PR Newswire
IntelGenx Enters into Feasibility Agreement with ATAI Life Sciences to Develop Pharmaceutical-Grade Polymeric Film-Based Psychedelics
From GlobeNewswire News Releases
IntelGenx Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
IntelGenx to Report Second Quarter 2020 Financial Results on August 13, 2020 – Conference Call to Follow
From GlobeNewswire News Releases
IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement
From GlobeNewswire News Releases
IntelGenx Reports Amendment of Stock Option Plan
From GlobeNewswire News Releases
Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 443
Tags Financial
From Investorideas.com newswire, breaking stock news and business news
IntelGenx and Cybin Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film
From GlobeNewswire News Releases
IntelGenx Announces Approval of Proposed Amendments to Convertible Debentures
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]